Riskpilot← Back to searchSign inGet full accessNEXTERA AS
ASActiveOrg 994486594Gaustadalléen 21, 0349 OsloResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20098 employeeswww.nextera.no
Revenue 2024
NOK 9,1M
-28% vs 2023
EBITDA margin
-385.9%
+11% vs 2023
Equity ratio
80.1%
Financial strength
Net profit 2024
NOK -35,9M
+9% vs 2023
| Revenue | NOK 9,1M | -28% |
| EBITDA | NOK -35M | +11% |
| Net profit | NOK -35,9M | +9% |
| Total assets | NOK 23,6M | +5% |
| Equity | NOK 18,9M | +28% |
| Employees | 8 | — |
Legal name
NEXTERA AS
Org number
994486594
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
14. september 2009
Share capital
NOK 4 158 563
Employees
8 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap. Styrets leder alene.
Company purpose
Utvikling av biomedisinske produkter og tjenester. Formålet kan fremmes ved deltakelse i eller samarbeid med andre foretak i inn- og utland eller rådgivende virksomhet.
Address
Gaustadalléen 21, 0349 Oslo
Phone
+4722958194
Email
info@nextera.no
Website
www.nextera.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 747 | 557 | 1 375 | 2 984 | 3 303 | 5 260 | 7 313 | 9 329 | 6 745 | 5 763 | 2 708 | 9 131 | 14 539 | 12 650 | 9 064 |
| Staff expenses | −0 | −98 | −640 | −1 228 | −2 755 | −3 494 | −4 826 | −6 588 | −8 041 | −8 865 | −8 563 | −9 574 | −11 024 | −13 027 | −17 714 | −18 616 |
| EBITDA | −88 | −1 056 | −2 335 | −2 086 | −3 372 | −3 809 | −4 613 | −5 695 | −7 524 | −9 877 | −11 277 | −18 571 | −14 241 | −18 223 | −39 253 | −34 979 |
| Depreciation & amort. | −0 | −0 | −22 | −72 | −208 | −208 | −231 | −267 | −312 | −271 | −303 | −391 | −339 | −653 | −1 272 | −1 351 |
| EBIT | −88 | −1 056 | −2 357 | −2 158 | −3 580 | −4 016 | −4 845 | −5 961 | −7 836 | −10 147 | −11 580 | −18 961 | −14 580 | −18 876 | −40 525 | −36 331 |
| Net financials | 0 | 1 | 3 | 0 | 36 | 46 | 127 | −166 | 101 | 142 | 101 | 15 | 20 | 211 | 1 055 | 442 |
| Profit before tax | −88 | −1 055 | −2 354 | −2 157 | −3 543 | −3 970 | −4 718 | −6 127 | −7 734 | −10 005 | −11 479 | −18 946 | −14 560 | −18 665 | −39 470 | −35 888 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −88 | −1 055 | −2 354 | −2 157 | −3 543 | −3 970 | −4 718 | −6 127 | −7 734 | −10 005 | −11 479 | −18 946 | −14 560 | −18 665 | −39 470 | −35 888 |
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 29 | 2 213 | 3 323 | 6 055 | 7 673 | 8 026 | 21 071 | 14 967 | 32 929 | 22 249 | 37 055 | 17 795 | 32 825 | 60 277 | 22 431 | 23 607 |
| Equity | 12 | 1 970 | 1 616 | 5 144 | 5 857 | 6 640 | 19 412 | 13 277 | 29 543 | 19 538 | 34 171 | 15 225 | 28 164 | 54 273 | 14 803 | 18 914 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 18 | 243 | 1 707 | 911 | 1 815 | 1 387 | 1 659 | 1 690 | 3 386 | 2 711 | 2 884 | 2 570 | 4 660 | 6 003 | 7 628 | 4 692 |
| Total debt | 18 | 243 | 1 707 | 911 | 1 815 | 1 387 | 1 659 | 1 690 | 3 386 | 2 711 | 2 884 | 2 570 | 4 660 | 6 003 | 7 628 | 4 692 |
EBITDA margin
-385.9%
This company
15.8%
Market median
-2542% vs market
20092024
Equity ratio
80.1%
This company
38.2%
Market median
+110% vs market
20092024
Return on equity
-189.7%
This company
18.4%
Market median
-1131% vs market
20092024
Net profit margin
-396.0%
This company
8.1%
Market median
-4989% vs market
20092024
Asset turnover
0.38×
This company
1.12×
Market median
-66% vs market
20092024
Debt / equity
0.25×
This company
0.62×
Market median
+60% vs market
20092024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-08-12 – 2009-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Radforsk Investeringsstiftelse | Company | 19.3% | 19.3% | 2024 |
Birk Venture As | Company | 15.1% | 15.1% | 2024 |
| Individual | 11.5% | 11.5% | 2022 | |
Sundt As | Company | 11.1% | 11.1% | 2024 |
Geveran Trading Company Ltd | Company | 8.2% | 8.2% | 2024 |
| Individual | 7.7% | 7.7% | 2022 | |
J.P. Morgan Se | Company | 7.3% | 7.3% | 2024 |
Ubs Switzerland Ag | Company | 7.3% | 7.3% | 2024 |
Ro Invest As | Company | 5.6% | 5.6% | 2024 |
| Individual | 5.3% | 5.3% | 2024 | |
Helene Sundt As | Company | 3.8% | 3.8% | 2024 |
Inven2 As | Company | 2.8% | 2.8% | 2024 |
| Individual | 2.0% | 2.0% | 2024 | |
Jandersen Kapital As | Company | 1.5% | 1.5% | 2024 |
Myrlid As | Company | 1.5% | 1.5% | 2024 |
As Bemacs | Company | 1.1% | 1.1% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NEXTERA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hans Ivar Robinson | Chairman | 0 companies |
| Martin Welschof | Board of Directors | 0 companies |
| Anders Tuv | Board of Directors | 0 companies |
| Bent Karsten Jakobsen | Board of Directors | 0 companies |
| Ole Henrik André Brekke | Board of Directors | 0 companies |
| Nicholas John Cross | Board of Directors | 0 companies |